Serum levels of phoenixin and nesfatin in patients with iron, vitamin B12 or vitamin D deficiency
a comparative study
Palabras clave:
Iron Deficiency, Nesfatin-1, Phoenixin-14, Vitamin B12 deficiency, Vitamin D deficiencyResumen
Objective
Micronutrient deficiencies are recognized as critical factors contributing to the global burden of disease. Phoenixin-14 and nesfatin-1 newly discovered neuropeptides which have been related to various physiological processes and potential therapeutic applications. This study was conducted to test whether circulating concentrations of nesfatin-1 and phoenixin-14 were altered in individuals with iron, vitamin B12, vitamin D and combined deficiencies.
Method
Our study group consists of 33 patients with iron deficiency, 30 patients with vitamin B12 deficiency, 33 patients with vitamin D deficiency, 32 patients with combined deficiency, 24 patients who received vitamin D supplementation and 32 control subjects. Serum nesfatin-1 and phoenixin-14 concentrations were determined measured by Enzyme-Linked ImmunoSorbent Assay method.
Results
Serum phoenixin-14 values were significantly lower in subjects with iron, vitamin B12, vitamin D and combined deficiency compared with the healthy group. After vitamin D supplementation, serum phoenixin-14 levels did not differ significantly with the healthy group. Serum nesfatin-1 concentrations were significantly lower in subjects with iron, vitamin B12 and combined deficiency compared with the healthy group. There was no significant difference in nesfatin-1 values between those with vitamin D deficiency, those taking vitamin D3 supplements and the healthy controls.
Conclusion
Significant differences in phoenixin-14 and nesfatin-1 levels between iron, vitamin D, vitamin B12 deficiency and the healthy control group supports that these molecules related to the pathogenesis of micronutrient deficiencies. Phoenixin-14 and nesfatin-1 may be considered potential biomarkers of micronutrient deficiencies.
Descargas
Citas
Tardy AL, Pouteau E, Marquez D, Yilmaz C, Scholey A. Vitamins and minerals for energy, fatigue and cognition: A narrative review of the biochemical and clinical evidence. Nutrients. 2020;12(1):228.
Han X, Ding S, Lu J, Li Y. Global, regional, and national burdens of common micronutrient deficiencies from 1990 to 2019: A secondary trend analysis based on the Global Burden of Disease 2019 study. EclinicalMedicine. 2022;44:101299. https://doi.org/10.1016/j.eclinm.2022.101299
Pike JW, Christakos S. Biology and mechanisms of action of the vitamin D hormone. Endocrinol Metab Clin North Am. 2017;46(4):815-43.
Bakke D, Sun J. Ancient Nuclear Receptor VDR with new functions: Microbiome and inflammation. Inflamm. Bowel Dis. 2018;24:1149-54.
Wimalawansa SJ. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. J Steroid Biochem Mol Biol. 2018;175:177-89.
Kumar A, Sharma E, Marley A, Samaan MA, Brookes MJ. Iron deficiency anaemia: Pathophysiology, assessment, practical management. BMJ Open Gastroenterol. 2022;9:e000759.
Camaschella C. Iron deficiency. Blood. 2019;133:30-9.
Green R, Allen LH, Bjorke-Monsen AL, Brito A, Gueant JL, Miller JW, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040. https://doi.org/10.1038/nrdp.2017.40
Oh IS, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709-12.
Rupp SK, Wölk E, Stengel A. Nesfatin-1 receptor: Distribution, signaling and ıncreasing evidence for a G Protein-Coupled Receptor: A systematic review. Front Endocrinol (Lausanne). 2021;12:740174.
Xu Y, Chen F. Antioxidant, anti-inflammatory and anti-apoptotic activities of Nesfatin-1: A review. J. Inflamm Res. 2020;13:607-17.
Yosten GL, Lyu RM, Hsueh AJ, Avsian-Kretchmer O, Chang JK, Tullock CW, et al. A novel reproductive peptide, phoenixin. J Neuroendocrinol. 2013;25:206-15. https://doi.org/10.1111/j.1365-2826.2012.02381.x
Friedrich T, Stengel A. Role of the novel peptide phoenixin in stress response and possible interactions with nesfatin-1. Int J Mol Sci. 2021;22:9156.
Zhang B, Li J. Phoenixin-14 protects human brain vascular endothelial cells against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced inflammation and permeability. Arch Biochem Biophys. 2020;682:108275.
Zeng X, Li Y, Ma S, Tang Y, Li H. Phoenixin-20 ameliorates lipopolysaccharide-induced activation of Microglial NLRP3 inflammasome. Neurotox Res. 2020;38:785-92.
Dore R, Levata L, Lehnert H, Schulz C. Nesfatin-1: Functions and physiology of a novel regulatory peptide. J Endocrinol. 2017;232:R45–R65.
Palasz A, Janas-Kozik M, Borrow A, Arias-Carrion O, Worthington JJ. The potential role of the novel hypothalamic neuropeptides nesfatin-1, phoenixin, spexin and kisspeptin in the pathogenesis of anxiety and anorexia nervosa. Neurochem Int. 2018; 113:120-36.
Goebel M, Stengel A, Wang L, Taché Y. Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals. Peptides. 2011;32:36-43.
Weibert E, Hofmann T, Elbelt U, Rose M, Stengel A. NUCB2/nesfatin-1 is associated with severity of eating disorder symptoms in female patients with obesity. Psychoneuroendocrinology. 2022;143:105842.
Dokumacioglu E, Iskender H, Sahin A, Erturk EY, Kaynar O. Serum levels of Nesfatin-1 and ırisin in obese children. Eur Cytokine Netw. 2020;31(1):39-43.
Abaci A, Catli G, Anik A, Kume T, Bober E. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diabetes. 2013;14:189-95.
Acar S, Çatlı G, Küme T, Tuhan H, Gürsoy Çalan Ö, Demir K, et al. Increased concentrations of serum nesfatin-1 levels in childhood with idiopathic chronic malnutrition. Turk J Med Sci. 2018;48:378-85. https://doi.org/10.3906/sag-1705-20
Kaba S, Karaman K, Kömüroğlu U, Bala KA, Demir N, Kocaman S, et al. Role of circulating nesfatin-1 in the underweight children with poor appetite. Eur Rev Med Pharmacol Sci. 2015;19(24):4703-6.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Sadinaz Akdu, Ummugulsum Can, Serdar Şahinoğlu
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
